v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities      
Net loss $ (98,539) $ (72,178)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 688 600  
Net accretion of discounts on marketable securities (1,211) (3,778)  
Stock-based compensation 14,536 10,237  
Amortization of right-of-use assets 455 533  
Changes in assets and liabilities      
Prepaid expenses and other assets 3,025 (1,970)  
Accounts payable 3,050 2,728  
Accrued and other liabilities 2,727 2,875  
Contract liabilities (587) 0  
Lease liabilities 686 611  
Net cash used in operating activities (75,170) (60,342)  
Cash flows from investing activities      
Purchases of property and equipment, net (967) (1,330)  
Purchases of marketable securities (42,610) (105,207)  
Maturities of marketable securities 162,529 186,354  
Net cash provided by investing activities 118,952 79,817  
Cash flows from financing activities      
Proceeds from issuance of common stock related to at-the-market offering program, net of issuance costs (9) 25,009  
Proceeds from exercise of common stock options 1,190 1,134  
Net cash provided by financing activities 1,181 26,143  
Net increase in cash, cash equivalents and restricted cash 44,963 45,618  
Cash, cash equivalents and restricted cash, at beginning of period 113,840 85,183 $ 85,183
Cash, cash equivalents and restricted cash, at end of period 158,803 130,801 113,840
Reconciliation of cash, cash equivalents and restricted cash      
Cash and cash equivalents 157,522 129,996 112,825
Restricted cash 1,281 805  
Cash, cash equivalents and restricted cash 158,803 130,801 $ 113,840
Supplemental non-cash investing and financing activities:      
Right-of-use asset obtained in exchange for a new operating lease liability 0 6,186  
Purchases of property and equipment in accounts payable and accrued liabilities 1,201 654  
Unpaid at-the-market offering program costs in accrued liabilities $ 98 $ 0